However, SwissChems has developed an innovative approach to circumvent these limitations, which constitutes a key differentiating factor for the company
In a 2018 study published in Current Pharmaceutical Design , researchers compared the effectiveness of BPC-157 to that of various standard peptidergic angiogenic growth factors (EGF, FGF, and VEGF) and numerous carriers for treating gastrointestinal ulcer healing and tendon, ligament, muscle, and bone healing
In the selected studies, participants were supplemented in a dose ranging from 1 g to 4,5 g per day for either 12 or 24 weeks, mostly by L-carnitine-L-tartrate (LCLT)
Embracing Uncertainty and Staying Current Nutrition science evolvesguidelines change as new data emerges (e.g., from low-fat to focusing on fat quality)